Skip to main content
Top
Published in: BMC Infectious Diseases 1/2006

Open Access 01-12-2006 | Research article

Soluble egg antigen of Schistosoma Haematobiuminduces HCV replication in PBMC from patients with chronic HCV infection

Authors: Mostafa K El-Awady, Samar S Youssef, Moataza H Omran, Ashraf A Tabll, Wael T El Garf, Ahmed M Salem

Published in: BMC Infectious Diseases | Issue 1/2006

Login to get access

Abstract

Background

This study was conducted to examine, in vitro , the effect of soluble egg antigen (SEA) of S. haematobium on intracellular HCV RNA load in peripheral mononuclear cells (PBMC) as well as on cell proliferation in patients with chronic HCV infection.

Methods

PBMC from 26 patients with chronic HCV infection were cultured for 72 hours in presence and absence of 50 μg SEA/ml medium. Intracellular HCV RNA quantification of plus and minus strands was assessed before and after stimulation. PBMC from five healthy subjects were cultured for 7 days, flow cytometric analysis of DNA content was used to assess the mitogenic effect of SEA on PBMC proliferation compared to phytoheamaglutinine (PHA).

Results

Quantification of the intracellular viral load showed increased copy number/cell of both or either viral strands after induction with SEA in 18 of 26 patients (69.2%) thus indicating stimulation of viral replication. Flow cytometric analysis showed that mean ± S.D. of percent values of cell proliferation was induced from 3.2 ± 1.5% in un-stimulated cells to 16.7 ± 2.5 % and 16.84 ± 1.7 % in cells stimulated with PHA and SEA respectively.

Conclusion

the present study supports earlier reports on SEA proliferative activity on PBMC and provides a strong evidence that the higher morbidity observed in patients co-infected with schistosomiasis and HCV is related, at least in part, to direct stimulation of viral replication by SEA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kamel MA, Ghaffar YA, Yasef MA, Wright M, Clark LC, Miller F: High HCV prevalence in Egyptian blood donors. Lancet. 1992, 340: 427-10.1016/0140-6736(92)91508-6.CrossRefPubMed Kamel MA, Ghaffar YA, Yasef MA, Wright M, Clark LC, Miller F: High HCV prevalence in Egyptian blood donors. Lancet. 1992, 340: 427-10.1016/0140-6736(92)91508-6.CrossRefPubMed
2.
go back to reference Darwish MA, Raouf TA, Rushdy P, Constantine N, Rao MR, Edelman R: Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg. 1993, 49: 440-447.PubMed Darwish MA, Raouf TA, Rushdy P, Constantine N, Rao MR, Edelman R: Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg. 1993, 49: 440-447.PubMed
3.
go back to reference Waked IA, Saleh SM, Moustafa MS, Raouf AA, Thomas DL, Strickland GT: High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut. 1995, 37: 105-107.CrossRefPubMedPubMedCentral Waked IA, Saleh SM, Moustafa MS, Raouf AA, Thomas DL, Strickland GT: High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut. 1995, 37: 105-107.CrossRefPubMedPubMedCentral
4.
go back to reference Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Ohn ESA, Anwar W, Sallam I: The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000, 355: 887-891. 10.1016/S0140-6736(99)06527-7.CrossRefPubMed Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Ohn ESA, Anwar W, Sallam I: The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000, 355: 887-891. 10.1016/S0140-6736(99)06527-7.CrossRefPubMed
5.
go back to reference WHO: Spread of hepatitis C linked to unsafe injection practices in Egypt. Bulletin of the world health organization. 2000, 78 (4): 562- WHO: Spread of hepatitis C linked to unsafe injection practices in Egypt. Bulletin of the world health organization. 2000, 78 (4): 562-
6.
go back to reference Saeed A, Al-Admawi AM, Al-Rasheed A, Fairclough D, Bacchus R: Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet. 1991, 338: 459-460. 10.1016/0140-6736(91)91094-B.CrossRefPubMed Saeed A, Al-Admawi AM, Al-Rasheed A, Fairclough D, Bacchus R: Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet. 1991, 338: 459-460. 10.1016/0140-6736(91)91094-B.CrossRefPubMed
7.
go back to reference El-Ahmady O, Halim A-B, Mansour O, Salman T: Incidence of hepatitis C virus in Egyptians. J Hepatol. 1994, 21: 687-10.1016/S0168-8278(94)80123-1.CrossRefPubMed El-Ahmady O, Halim A-B, Mansour O, Salman T: Incidence of hepatitis C virus in Egyptians. J Hepatol. 1994, 21: 687-10.1016/S0168-8278(94)80123-1.CrossRefPubMed
8.
go back to reference Badawi AF, Michael MS: Risk factors for hepatocellular carcinoma in Egypt: the role of hepatitis-B viral infection and schistosomiasis. Anticancer Res. 1999, 19: 4565-9.PubMed Badawi AF, Michael MS: Risk factors for hepatocellular carcinoma in Egypt: the role of hepatitis-B viral infection and schistosomiasis. Anticancer Res. 1999, 19: 4565-9.PubMed
9.
go back to reference Aquino RT, Chieffi PP, Catunda SM, et al: Hepatitis B and C virus markers among patients with hepatosplenic mansonic schistosomiasis. Rev Inst Med Trop Sao Paulo. 2000, 42: 313-20.CrossRefPubMed Aquino RT, Chieffi PP, Catunda SM, et al: Hepatitis B and C virus markers among patients with hepatosplenic mansonic schistosomiasis. Rev Inst Med Trop Sao Paulo. 2000, 42: 313-20.CrossRefPubMed
10.
go back to reference Kamal SM, Graham CS, He Q, Bianchi L, Tawil AA, Rasenack JW, Khalifa KA, Massoud MM, Koziel MJ: Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J Infect Dis. 2004, 1;189 (7): 1140-50. 10.1086/382278.CrossRef Kamal SM, Graham CS, He Q, Bianchi L, Tawil AA, Rasenack JW, Khalifa KA, Massoud MM, Koziel MJ: Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J Infect Dis. 2004, 1;189 (7): 1140-50. 10.1086/382278.CrossRef
11.
go back to reference El Ridi R, Ismail S, Gaafar T, El Demellawy M: Differential responsiveness of humans with early-stage schistosomiasis haematobium to Schistosoma haematobium soluble adult-worm and egg antigens. Parasitol Res. 1997, 83 (5): 471-7. 10.1007/s004360050282.CrossRefPubMed El Ridi R, Ismail S, Gaafar T, El Demellawy M: Differential responsiveness of humans with early-stage schistosomiasis haematobium to Schistosoma haematobium soluble adult-worm and egg antigens. Parasitol Res. 1997, 83 (5): 471-7. 10.1007/s004360050282.CrossRefPubMed
12.
go back to reference Freedman DO, Ottsen EA: Eggs of schistosoma mansoni stimulate endothelial cell proliferation in vitro . Infectious diseases. 1989, 158: 556-CrossRef Freedman DO, Ottsen EA: Eggs of schistosoma mansoni stimulate endothelial cell proliferation in vitro . Infectious diseases. 1989, 158: 556-CrossRef
13.
go back to reference Almeida CA, Leite MF, Goes AM: Signal transduction events in peripheral blood mononuclear cells stimulated by Schistosoma mansoni antigens. Hum Immunol. 2001, 62 (10): 1159-66. 10.1016/S0198-8859(01)00302-0.CrossRefPubMed Almeida CA, Leite MF, Goes AM: Signal transduction events in peripheral blood mononuclear cells stimulated by Schistosoma mansoni antigens. Hum Immunol. 2001, 62 (10): 1159-66. 10.1016/S0198-8859(01)00302-0.CrossRefPubMed
14.
go back to reference El Awady MK, Gad YZ, Wen Y, Essawi M, Effat L, Amr KS, Ismail S, Christ GJ: Schistosoma hematobium soluble egg antigen induces proliferation of urothelial and endothelial cells. World J Urol. 2001, 19: 263-10.1007/s003450100217.CrossRefPubMed El Awady MK, Gad YZ, Wen Y, Essawi M, Effat L, Amr KS, Ismail S, Christ GJ: Schistosoma hematobium soluble egg antigen induces proliferation of urothelial and endothelial cells. World J Urol. 2001, 19: 263-10.1007/s003450100217.CrossRefPubMed
15.
go back to reference Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol cloroform extraction. Anal Biochem. 1987, 162: 156-10.1016/0003-2697(87)90021-2.CrossRefPubMed Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol cloroform extraction. Anal Biochem. 1987, 162: 156-10.1016/0003-2697(87)90021-2.CrossRefPubMed
16.
go back to reference Angelico M, Renganathan E, Gandin C, Fathy M, Profili MC, Refai W, De Santis A, Nagi A, Amin G, Capocaccia L, Callea F, Rapicetta M, Badr G, Rocchi G: Chronic liver disease in the Alexandria governorate, Egypt: combination of Schistosomiasis and virus infections. J hepatol. 1997, 26: 236-10.1016/S0168-8278(97)80036-0.CrossRefPubMed Angelico M, Renganathan E, Gandin C, Fathy M, Profili MC, Refai W, De Santis A, Nagi A, Amin G, Capocaccia L, Callea F, Rapicetta M, Badr G, Rocchi G: Chronic liver disease in the Alexandria governorate, Egypt: combination of Schistosomiasis and virus infections. J hepatol. 1997, 26: 236-10.1016/S0168-8278(97)80036-0.CrossRefPubMed
17.
go back to reference Halim AB, Garry RF, Dash S, Gribier MA: Effect of schistosomiasis and hepatitis on liver disease. Am J Trop Med Hyg. 1999, 60 (6): 915-PubMed Halim AB, Garry RF, Dash S, Gribier MA: Effect of schistosomiasis and hepatitis on liver disease. Am J Trop Med Hyg. 1999, 60 (6): 915-PubMed
18.
go back to reference Zaki A, Bassili A, Amin G, Aref T, Kandil M, Abou Basha LM: Morbidity of schistosomiasis mansoni in rural Alexandria, Egypt. J Egypt Soc Parasitol. 2003, 33 (3): 695-710.PubMed Zaki A, Bassili A, Amin G, Aref T, Kandil M, Abou Basha LM: Morbidity of schistosomiasis mansoni in rural Alexandria, Egypt. J Egypt Soc Parasitol. 2003, 33 (3): 695-710.PubMed
19.
go back to reference Buratti E, Tisminetzky S, Zotti M, Baralle FE: Functional analysis of the interaction between HCV 5' UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Research. 1998, 26 (13): 3179-3187. 10.1093/nar/26.13.3179.CrossRefPubMedPubMedCentral Buratti E, Tisminetzky S, Zotti M, Baralle FE: Functional analysis of the interaction between HCV 5' UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Research. 1998, 26 (13): 3179-3187. 10.1093/nar/26.13.3179.CrossRefPubMedPubMedCentral
20.
go back to reference Fukushi S, Okada M, Stahli J, Kageyama T, Hoshino FB, Kazuhiko Katayama: Ribosomal Protein S5 Interacts with the Internal Ribosomal Entry Site of Hepatitis C Virus. The J of Biological Chemistry. 2001, 276 (24): 20824-20826. 10.1074/jbc.C100206200. Issue of June 15CrossRef Fukushi S, Okada M, Stahli J, Kageyama T, Hoshino FB, Kazuhiko Katayama: Ribosomal Protein S5 Interacts with the Internal Ribosomal Entry Site of Hepatitis C Virus. The J of Biological Chemistry. 2001, 276 (24): 20824-20826. 10.1074/jbc.C100206200. Issue of June 15CrossRef
21.
go back to reference Gontarek RR, Gutshall LL, Herold KM, Tsai J, Sathe GM, Mao J, Prescott G, Del Vecchio AM: hnRNPC and polypyrimidine tract-binding protein specifically interact with the pyrimidine-rich region with the 3' NTR of the HCV genome. Nucleic Acids Research. 1999, 27 (6): 1457-10.1093/nar/27.6.1457.CrossRefPubMedPubMedCentral Gontarek RR, Gutshall LL, Herold KM, Tsai J, Sathe GM, Mao J, Prescott G, Del Vecchio AM: hnRNPC and polypyrimidine tract-binding protein specifically interact with the pyrimidine-rich region with the 3' NTR of the HCV genome. Nucleic Acids Research. 1999, 27 (6): 1457-10.1093/nar/27.6.1457.CrossRefPubMedPubMedCentral
22.
go back to reference Krecic AM, Swanson MS: hnRNP complexes: composition, structure and function. Curr Opin Cell Biol. 1999, 363: 71- Krecic AM, Swanson MS: hnRNP complexes: composition, structure and function. Curr Opin Cell Biol. 1999, 363: 71-
23.
go back to reference Kamal S, Madwar M, Bianchi L, Tawil AE, Fawzy R, Peters T, Rasenack JW: Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver. 2000, 20 (4): 281-9. 10.1034/j.1600-0676.2000.020004281.x.CrossRefPubMed Kamal S, Madwar M, Bianchi L, Tawil AE, Fawzy R, Peters T, Rasenack JW: Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver. 2000, 20 (4): 281-9. 10.1034/j.1600-0676.2000.020004281.x.CrossRefPubMed
24.
go back to reference Kamal S, Bianchi L, Al Tawil A, Koziel M, El Sayed Khalifa K, Peter T, Rasenack JW: Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni. J Infect Dis. 2001, 15;184 (8): 972-82. 10.1086/323352.CrossRef Kamal S, Bianchi L, Al Tawil A, Koziel M, El Sayed Khalifa K, Peter T, Rasenack JW: Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni. J Infect Dis. 2001, 15;184 (8): 972-82. 10.1086/323352.CrossRef
25.
go back to reference Pham TN, Macparland SA, Coffin CS, Lee SS, Bursey FR, Michalak TI: Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol. 2005, 86 (Pt 3): 657-66. 10.1099/vir.0.80624-0.CrossRefPubMed Pham TN, Macparland SA, Coffin CS, Lee SS, Bursey FR, Michalak TI: Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol. 2005, 86 (Pt 3): 657-66. 10.1099/vir.0.80624-0.CrossRefPubMed
26.
go back to reference Kuruda H, Yasunaga Y, Takatera H, Fujioka H, Ohnishi A, Tsujimoyo M: growth factors of bladder cancer determined by proliferating cell nuclear antigen immunostaining. Hinyokika Kiyo. 1994, 40 (5): 379-82. Kuruda H, Yasunaga Y, Takatera H, Fujioka H, Ohnishi A, Tsujimoyo M: growth factors of bladder cancer determined by proliferating cell nuclear antigen immunostaining. Hinyokika Kiyo. 1994, 40 (5): 379-82.
27.
go back to reference Wada T, Shimabukuro T, Kurisu H, Shameam IA, Yashihiro S, Matsuyama H, Naito K, Hashimoto O, Tanaka K: Expression of proliferation cell nuclear antigen in superficial bladder cancer-application to paraffin-embeded tissue sections. Hinyokika Kiyo. 1993, 39: 313-319.PubMed Wada T, Shimabukuro T, Kurisu H, Shameam IA, Yashihiro S, Matsuyama H, Naito K, Hashimoto O, Tanaka K: Expression of proliferation cell nuclear antigen in superficial bladder cancer-application to paraffin-embeded tissue sections. Hinyokika Kiyo. 1993, 39: 313-319.PubMed
28.
go back to reference Gaafar T, Ismail S, Helmy M, Afifi A, Guirguis N, el Ridi R: Identification of Schistosoma haematobium soluble egg antigens that elicit human granuloma formation in vitro . Parasitol Res. 1993, 79 (2): 103-8. 10.1007/BF00932254.CrossRefPubMed Gaafar T, Ismail S, Helmy M, Afifi A, Guirguis N, el Ridi R: Identification of Schistosoma haematobium soluble egg antigens that elicit human granuloma formation in vitro . Parasitol Res. 1993, 79 (2): 103-8. 10.1007/BF00932254.CrossRefPubMed
29.
go back to reference Loeffler DA, Lundy SK, Singh KP, Gerard HC, Hudson AP, Boros DL: Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells. J Infect Dis. 2002, 1;185 (11): 1650-6. 10.1086/340416.CrossRef Loeffler DA, Lundy SK, Singh KP, Gerard HC, Hudson AP, Boros DL: Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells. J Infect Dis. 2002, 1;185 (11): 1650-6. 10.1086/340416.CrossRef
30.
go back to reference Imura S, Miyake H, Izumi K, Tashiro S, Uehara H: Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma. J Med Invest. 2004, 51 (3–4): 202-9. 10.2152/jmi.51.202.CrossRefPubMed Imura S, Miyake H, Izumi K, Tashiro S, Uehara H: Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma. J Med Invest. 2004, 51 (3–4): 202-9. 10.2152/jmi.51.202.CrossRefPubMed
31.
go back to reference Muller HM, Pfaff E, Goeser T, kallinowski B, Salbach C, Theilmann L: Peripheral blood leukocytes serve as possible extrahepatic site for hepatitis C virus replication. J Gen Virol. 1993, 74: 669-CrossRefPubMed Muller HM, Pfaff E, Goeser T, kallinowski B, Salbach C, Theilmann L: Peripheral blood leukocytes serve as possible extrahepatic site for hepatitis C virus replication. J Gen Virol. 1993, 74: 669-CrossRefPubMed
32.
go back to reference Laskus T, Radkowski M, Piasek A, Nowicki M, Horban A, Cianciara J, Rakcla J: Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocyte/macrophages and lymphocytes. J Infect Dis. 2000, 181: 442-10.1086/315283.CrossRefPubMed Laskus T, Radkowski M, Piasek A, Nowicki M, Horban A, Cianciara J, Rakcla J: Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocyte/macrophages and lymphocytes. J Infect Dis. 2000, 181: 442-10.1086/315283.CrossRefPubMed
33.
go back to reference El Awady MK, Abdel Rahman MM, Ismail SM, Amr KS, Omran M, Mohamed SA: Prediction of relapse after interferon therapy in hepatitis C virus infected by the use of triple assay. Journal of Gastroenterology and Hepatology. 2002, 18: 68-10.1046/j.1440-1746.2003.02919.x.CrossRef El Awady MK, Abdel Rahman MM, Ismail SM, Amr KS, Omran M, Mohamed SA: Prediction of relapse after interferon therapy in hepatitis C virus infected by the use of triple assay. Journal of Gastroenterology and Hepatology. 2002, 18: 68-10.1046/j.1440-1746.2003.02919.x.CrossRef
34.
go back to reference EL-Awady MK, Tabll A, Redwan E, Youssef SS, Omran MH, Thakeb F, El-Demellawy M: Flow Cytometric Detection of Hepatitis C Virus Antigens In Infected Peripheral Blood Leukocytes: Binding and Entry. world. J Gastroenterol. 2005, 11 (33): 5203-5208. EL-Awady MK, Tabll A, Redwan E, Youssef SS, Omran MH, Thakeb F, El-Demellawy M: Flow Cytometric Detection of Hepatitis C Virus Antigens In Infected Peripheral Blood Leukocytes: Binding and Entry. world. J Gastroenterol. 2005, 11 (33): 5203-5208.
35.
go back to reference Sansonno D, Lacobelli AR, Cornachiulo V, Iodice G, Dammacco F: Detection of HCV proteins by immunofluoresence and HCV RNA genomic sequences by non -isotopic in situ hybridization in bone marrow cells and PBMC of chronically HCV infected patients. Clin Exp Immunol. 1996, 103: 414-21.CrossRefPubMedPubMedCentral Sansonno D, Lacobelli AR, Cornachiulo V, Iodice G, Dammacco F: Detection of HCV proteins by immunofluoresence and HCV RNA genomic sequences by non -isotopic in situ hybridization in bone marrow cells and PBMC of chronically HCV infected patients. Clin Exp Immunol. 1996, 103: 414-21.CrossRefPubMedPubMedCentral
36.
37.
go back to reference Ishii A, Matsuoka H, Aji T, Hayatsu H, Wataya Y, Arimoto S, Tokuda H: Evaluation of the mutagenicity and the tumor-promoting activity of parasite extracts: Schistosoma japonicum and Clonorchis sinensis. Mutat Res. 1989, 224 (2): 229-33. 10.1016/0165-1218(89)90160-2.CrossRefPubMed Ishii A, Matsuoka H, Aji T, Hayatsu H, Wataya Y, Arimoto S, Tokuda H: Evaluation of the mutagenicity and the tumor-promoting activity of parasite extracts: Schistosoma japonicum and Clonorchis sinensis. Mutat Res. 1989, 224 (2): 229-33. 10.1016/0165-1218(89)90160-2.CrossRefPubMed
Metadata
Title
Soluble egg antigen of Schistosoma Haematobiuminduces HCV replication in PBMC from patients with chronic HCV infection
Authors
Mostafa K El-Awady
Samar S Youssef
Moataza H Omran
Ashraf A Tabll
Wael T El Garf
Ahmed M Salem
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2006
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-6-91

Other articles of this Issue 1/2006

BMC Infectious Diseases 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.